Jeanette Boudreau

Researcher

Dalhousie University

Related Research

Related News & Events

TFRI News|November 12, 2024

Eight pan-Canadian research teams receive newly created TFRI-MOHCCN Technology Development Awards

New joint funding initiative from TFRI and the MOHCCN will support the deployment of novel technologies to accelerate precision medicine for cancer.

Research Highlight|October 30, 2024

Identifying immune patterns to personalize ovarian cancer therapy

Immunotherapy, which harnesses the body’s natural defense against cancer, has shown success in some cancers, but so far, it hasn’t been successful for...

Research Highlight|May 09, 2023

PROJECT UPDATE: A Q&A with Dr. Jeanette Boudreau, Halifax-based Terry Fox New Investigator, on harnessing the power of natural killer cells for immunotherapy in ovarian cancers

We interviewed Dr. Jeanette Boudreau, a Halifax-based Terry Fox New Investigator who has identified a panel of markers that can be used to define natu...

Research Highlight|June 03, 2019

New finding may aid in prediction of aggressiveness of colorectal cancer

The deletion of Interleukin-17 receptor (IL-17R), a receptor gene that regulates inflammation, may help predict the aggressiveness of colorectal cance...

Press Release|December 11, 2018

Outstanding researchers from Montreal, Halifax and Toronto receive $1.35 million to find new treatments for metastatic and ovarian cancers

Three outstanding early-career investigators from Montreal, Halifax and Toronto will each receive $450,000 over the next three years to explore new tr...

All News & Events

Jeanette Boudreau

Funding Opportunities

Our Research

Impact

About Cancer

Updates

About Us

Contact